GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,505 Cr | ₹1,273 Cr | ₹1,168 Cr | ₹2,009 Cr | ₹668 Cr |
What is the latest Net Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,505 Cr |
| Mar2024 | ₹1,273 Cr |
| Mar2023 | ₹1,168 Cr |
| Mar2022 | ₹2,009 Cr |
| Mar2021 | ₹668 Cr |
How is Net Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,505 Cr | 18.16 | |
| Mar2024 | ₹1,273 Cr | 9.04 | |
| Mar2023 | ₹1,168 Cr | -41.88 | |
| Mar2022 | ₹2,009 Cr | 200.85 | |
| Mar2021 | ₹668 Cr | - | |
Compare Net Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,226.0 Cr | -2.1% | -6.2% | -9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -2.1% |
-6.2% |
-9.4% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses